Skip to main content
H.R. 1035 116th Congress House

Prescription Drug Price Transparency Act

Official title: To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Ad… Show full official titleShow less

Official title: To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program and Medicare Advantage program to further transparency of payment methodologies to pharmacies, and for other purposes.

Introduced: February 7, 2019 See on congress.gov
Health Administrative remediesConsumer affairsContracts and agencyHealth care costs and insurance
More subjectsShow fewer subjects
Health information and medical recordsInsurance industry and regulationMedical ethicsMedicarePrescription drugsPublic contracts and procurementRetail and wholesale trades
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 7, 2019
Referred to the Subcommittee on Health.
Feb 7, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 7, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 7, 2019

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Prescription Drug Price Transparency Act

This bill establishes additional requirements for prescription drug plan sponsors (PDPs) under Medicare and Medicare Advantage, as well as health insurance carriers under the Federal Employees Health Benefits Program, relating to the methodology of payments to pharmacies and the use of pharmacy benefits managers (PBMs).

Specifically, such PDPs and carriers must disclose specified information to pharmacies regarding applicable standards for reimbursement that are based on drug costs, including the sources used to update such standards. Additionally, such PDPs and carriers may not contract with PBMs that require, or that provide an incentive for, plan enrollees to use pharmacies that have a shared ownership interest with the PBM.

 Related & companion bills 3
  • HR 1332 Fair Care Act of 2019
  • S 4796 Fair Care Act of 2020
  • HR 8527 Fair Care Act of 2020
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 30
All 30 Democratic 6 Republican 13
R
Thompson, Glenn
Pennsylvania · Apr 28, 2020
Keller, Fred
· Nov 20, 2019
 R
Cline, Ben
Virginia · Jul 24, 2019
 R
Rogers, Mike D.
Alabama · May 30, 2019
Gabbard, Tulsi
· May 16, 2019
 R
Meuser, Daniel
Pennsylvania · May 14, 2019
 R
Loudermilk, Barry
Georgia · May 7, 2019
VISCLOSKY, PETER
· May 1, 2019
 D
Davids, Sharice
Kansas · Apr 18, 2019
 R
Hill, J. French
Arkansas · Apr 18, 2019
Brooks, Mo
· Apr 12, 2019
 D
Doggett, Lloyd
Texas · Apr 10, 2019
Roby, Martha
· Apr 3, 2019
 R
Budd, Ted
North Carolina · Apr 2, 2019
Palazzo, Steven
· Mar 28, 2019
 R
Marshall, Roger
Kansas · Mar 27, 2019
 D
Gonzalez, Vicente
Texas · Mar 18, 2019
Herrera Beutler, Jaime
· Mar 5, 2019
 R
Newhouse, Dan
Washington · Feb 25, 2019
Byrne, Bradley
· Feb 7, 2019
 R
Carter, Earl L. "Buddy"
Georgia · Feb 7, 2019
 D
Clarke, Yvette D.
New York · Feb 7, 2019
 R
Crawford, Eric A. "Rick"
Arkansas · Feb 7, 2019
Hice, Jody
· Feb 7, 2019
King, Steve
· Feb 7, 2019
 D
Raskin, Jamie
Maryland · Feb 7, 2019
 R
Scott, Austin
Georgia · Feb 7, 2019
Vela, Filemon
· Feb 7, 2019
 D
Welch, Peter
Vermont · Feb 7, 2019
 R
Westerman, Bruce
Arkansas · Feb 7, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1035: Prescription Drug Price Transparency Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-1035/
MLA
"H.R. 1035: Prescription Drug Price Transparency Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-1035/.
Bluebook (legal)
H.R. 1035, 116th Cong. (2026), https://openamerica.io/bill/116-HR-1035/.
Markdown link
[H.R. 1035: Prescription Drug Price Transparency Act](https://openamerica.io/bill/116-HR-1035/)
Report a problem